| The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer RM Bremnes, T Dønnem, S Al-Saad, K Al-Shibli, S Andersen, R Sirera, ... Journal of thoracic oncology 6 (1), 209-217, 2011 | 734 | 2011 |
| Prognostic effect of epithelial and stromal lymphocyte infiltration in non–small cell lung cancer KI Al-Shibli, T Donnem, S Al-Saad, M Persson, RM Bremnes, LT Busund Clinical cancer research 14 (16), 5220-5227, 2008 | 709 | 2008 |
| The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer RM Bremnes, LT Busund, TL Kilvær, S Andersen, E Richardsen, ... Journal of Thoracic Oncology 11 (6), 789-800, 2016 | 457 | 2016 |
| The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer RM Bremnes, K Al-Shibli, T Donnem, R Sirera, S Al-Saad, S Andersen, ... Journal of Thoracic Oncology 6 (4), 824-833, 2011 | 374 | 2011 |
| Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer T Donnem, SM Hald, EE Paulsen, E Richardsen, S Al-Saad, TK Kilvaer, ... Clinical Cancer Research 21 (11), 2635-2643, 2015 | 304 | 2015 |
| Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer T Donnem, TK Kilvaer, S Andersen, E Richardsen, EE Paulsen, SM Hald, ... Annals of oncology 27 (2), 225-232, 2016 | 181 | 2016 |
| The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer S Al-Saad, K Al-Shibli, T Donnem, M Persson, RM Bremnes, LT Busund British journal of cancer 99 (9), 1476-1483, 2008 | 179 | 2008 |
| Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch‐1 and vascular endothelial growth factor‐A predicts poor survival T Donnem, S Andersen, K Al‐Shibli, S Al‐Saad, LT Busund, RM Bremnes Cancer 116 (24), 5676-5685, 2010 | 170 | 2010 |
| Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non–small cell lung cancer T Donnem, S Al-Saad, K Al-Shibli, MP Delghandi, M Persson, MN Nilsen, ... Clinical Cancer Research 13 (22), 6649-6657, 2007 | 149 | 2007 |
| Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells T Donnem, S Al-Saad, K Al-Shibli, S Andersen, LT Busund, RM Bremnes Journal of Thoracic Oncology 3 (9), 963-970, 2008 | 137 | 2008 |
| Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization T Donnem, K Eklo, T Berg, SW Sorbye, K Lonvik, S Al-Saad, K Al-Shibli, ... Journal of translational medicine 9, 1-9, 2011 | 135 | 2011 |
| MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer T Donnem, CG Fenton, K Lonvik, T Berg, K Eklo, S Andersen, H Stenvold, ... PloS one 7 (1), e29671, 2012 | 133 | 2012 |
| The prognostic value of intraepithelial and stromal innate immune system cells in non‐small cell lung carcinoma K Al‐Shibli, S Al‐Saad, T Donnem, M Persson, RM Bremnes, LT Busund Histopathology 55 (3), 301-312, 2009 | 125 | 2009 |
| Prognostic value of macrophage phenotypes in resectable non–small cell lung cancer assessed by multiplex immunohistochemistry M Rakaee, LTR Busund, S Jamaly, EE Paulsen, E Richardsen, ... Neoplasia 21 (3), 282-293, 2019 | 121 | 2019 |
| Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure‐free survival in prostate cancer N Ness, S Andersen, A Valkov, Y Nordby, T Donnem, S Al‐Saad, ... The Prostate 74 (14), 1452-1461, 2014 | 121 | 2014 |
| Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality E Richardsen, RD Uglehus, SH Johnsen, LT Busund Anticancer research 35 (2), 865-874, 2015 | 120 | 2015 |
| Prognostic impact of lymphocytes in soft tissue sarcomas SW Sorbye, T Kilvaer, A Valkov, T Donnem, E Smeland, K Al-Shibli, ... PLoS One 6 (1), e14611, 2011 | 116 | 2011 |
| Significant expression of IGFBP2 in breast cancer compared with benign lesions LT Busund, E Richardsen, R Busund, T Ukkonen, T Bjørnsen, C Busch, ... Journal of clinical pathology 58 (4), 361-366, 2005 | 116 | 2005 |
| Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer: Coexpression with vascular endothelial growth factor‐A predicts poor survival T Donnem, K Lonvik, K Eklo, T Berg, SW Sorbye, K Al‐Shibli, S Al‐Saad, ... Cancer 117 (14), 3193-3200, 2011 | 106 | 2011 |
| COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67 E Richardsen, RD Uglehus, J Due, C Busch, LT Busund Cancer epidemiology 34 (3), 316-322, 2010 | 106 | 2010 |
